Search Results

GSK2656157 100 mg  | 99.89%

TargetMol

GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.

More Information Supplier Page

GSK2656157 10 mg  | 99.89%

TargetMol

GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.

More Information Supplier Page

CEP-37440 10 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 2 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 50 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 5 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

Ro3280 10 mg  | Purity Not Available

TargetMol

Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM).

More Information Supplier Page

UNC2881 5 mg  | 99.72%

TargetMol

UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively.

More Information Supplier Page

UNC2881 50 mg  | 99.72%

TargetMol

UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively.

More Information Supplier Page